NanoViricides (NYSE-A:NNVC), a clinical-stage antiviral drug developer, is presenting at the MicroCap Conference 2025 in Atlantic City on January 29 at 11:00 am.
Anil R. Diwan, PhD, President and Executive Chairman, will provide updates on the company’s drug pipeline and licensing opportunities.
The event, held at The Borgata Hotel, is open to all attendees.
NanoViricides specializes in broad-spectrum antiviral drugs designed to prevent viral escape.